Clinical trial
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
NCT02336243
Study timeline
Study start (unknown)2015-05-01Date precision: month
Registry last updated2015-11-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Premature Birthunresolved
Preeclampsiaunresolved
Fetal Growth Retardationunresolved
Stillbirthunresolved
Interventions
Docosahexaenoic acid (DHA)DIETARY_SUPPLEMENT
Placebo (for Docosahexaenoic acid (DHA))DIETARY_SUPPLEMENT
Sponsors & collaborators
Pontificia Universidad Catolica de Chilelead sponsor
University of Chilecollaborator
Laboratorio Gynopharm - CFRcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02336243 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.